On September 25, 2017, the FDA and lupus patients came together for a historic patient-focused drug development meeting.
The Lupus Patient-Focused Drug Development (PFDD) Meeting, a day-long event to advance lupus therapy development and inform FDA will be held Sept. 25.
This new research program provides $5 million that will greatly expand the number of lupus-specific research studies that can be supported through the DoD.
LupusConnect brings together people impacted by lupus to share experiences and find timeless support.
We're working to ensure that the new funding is directed to research projects that can make the most difference.
House Appropriations Committee Approves Lupus Research and Education Funding as Senate Continues Debate on Health Reform
Advocates earn a significant victory for lupus research as House Appropriations bill passes with additional $5 million in funding for the Lupus Research Program at the DoD.
On June 27, nearly 200 lupus activists from across the country will visit Capitol Hill and thousands more will join virtually.